|
Volumn 31, Issue 1, 2002, Pages 166-167
|
Commentary: Estimating direct and indirect effects - Fallible in theory, but in the real world?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
EPIDEMIOLOGY;
HEALTH RISK;
METHODOLOGY;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EXPOSURE;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
NOTE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
STATISTICAL ANALYSIS;
STATISTICS;
THROMBOCYTE AGGREGATION;
TREATMENT OUTCOME;
|
EID: 0036210926
PISSN: 03005771
EISSN: None
Source Type: Journal
DOI: 10.1093/ije/31.1.166 Document Type: Note |
Times cited : (40)
|
References (9)
|